rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia ( Deficiency)
Background . Congenital disorders of glycosylation (CDG) are a group of rare disorders in which glycosylation required for proper protein-protein interactions and protein stability is disrupted, manifesting clinically with multiple system involvement and growth failure. The insulin-like growth facto...
Main Authors: | Bradley S. Miller MD, PhD, Meghann M. Duffy MD, O. Yaw Addo PhD, Kyriakie Sarafoglou MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-09-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709613503316 |
Similar Items
-
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: Post-hoc Analysis of Its Effect on Brain Injury
by: Sandra Horsch, et al.
Published: (2020-10-01) -
Molecular Imaging of IGF-1R in Cancer
by: Yingying Sun PhD, et al.
Published: (2017-11-01) -
The growth hormone/insulin-like growth factor I axis in insulin-dependent diabetes mellitus during adolescence : studies of recombinant human insulin-like growth factor I (rhIGF-I) administration
by: Cheetham, Tim D.
Published: (1996) -
Role of IGF-1R in ameliorating apoptosis of GNE deficient cells
by: Reema Singh, et al.
Published: (2018-05-01) -
Autophagy resolves early retinal inflammation in Igf1-deficient mice
by: Ana I. Arroba, et al.
Published: (2016-09-01)